Geode Capital Management
AVNR

Geode Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Geode Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,112,115
Closed -$18.9M – 4040
2014
Q4 		$18.9M Buy
1,112,115
+138,164
+14% +$1.94M 0.01% 905
2014
Q3 		$11.6M Buy
973,951
+93,718
+11% +$640K 0.01% 1150
2014
Q2 		$4.96M Buy
880,233
+108,341
+14% +$499K ﹤0.01% 1799
2014
Q1 		$2.83M Buy
771,892
+68,435
+10% +$261K ﹤0.01% 2134
2013
Q4 		$2.36M Buy
703,457
+36,861
+6% +$152K ﹤0.01% 2191
2013
Q3 		$2.83M Buy
666,596
+61,389
+10% +$291K ﹤0.01% 1966
2013
Q2 		$2.78M Buy
+605,207
New +$2.08M ﹤0.01% 1829

Geode Capital Management's AVNR Position: Q1 2015 in Review

Geode Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,112,115 shares — an estimated $18.9M sold.

Geode Capital Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $18.9M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Geode Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Geode Capital Management sold 1,112,115 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $18.9M.
  • Geode Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Geode Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $18.9M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Geode Capital Management's 13F filing for Q1 2015, filed 14 May 2015.